Literature DB >> 8808495

Women have a larger and less atherogenic low density lipoprotein particle size than men.

M Nikkilä1, T Pitkäjärvi, T Koivula, T Solakivi, T Lehtimäki, P Laippala, H Jokela, E Lehtomäki, K Seppä, P Sillanaukee.   

Abstract

Some epidemiological studies have shown that serum total cholesterol increases with age. especially in women. On the other hand, the risk of coronary artery disease is smaller in women than in men. Earlier studies have shown that a small dense low density lipoprotein (LDL) is more atherogenic than a large LDL. We studied LDL size and apolipoprotein E (apo E) phenotypes in premenopausal and postmenopausal women and in men at the same age. In this study 342 subjects participating in a health screening study were examined. There were four subgroups: 40-year-old men (n = 85), 40-year-old women (n = 80), 70-year old men (n = 88) and 70-year-old women (n = 89). In the present study LDL size was larger (P < 0.01) in women (26.39 +/- 0.07 nm) than in men (25.95 +/- 0.07 nm). We found that LDL size correlated highly positively (r = 0.606; P < 0.001) with serum high density lipoprotein (HDL) concentration and inversely with serum triglyceride concentration (r = -0.627; P < 0.001). Measuring serum HDL cholesterol and triglycerides in health screening studies gives information indirectly about LDL size and its atherogenicity. Apo E phenotype was not significantly associated with serum triglycerides, but was associated with LDL size, LDL cholesterol, total cholesterol and HDL cholesterol. In our sample LDL size decreased and LDL cholesterol and total cholesterol increased according to the most prevalent apo E phenotypes in the order E2/3, E3/3, E3/4 and E4/4. Subjects with phenotype apo E4/4 had the smallest LDL size (25.70 +/- 0.19 nm), the highest total cholesterol (6.53 +/- 0.35 mmol/l) and the lowest HDL cholesterol values (1.28 +/- 0.04 mmol/l). We conclude that there was a significant interaction between sex and age in serum total cholesterol which was highest in older women. However, their LDL size was larger and their LDL is less atherogenic. Apo E phenotype had a significant influence on LDL size.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808495     DOI: 10.1016/0021-9150(95)05645-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

1.  LDL particle heterogeneity, and its association with other established cardiovascular risk factors in a young Indian industrial population.

Authors:  Ramakrishnan Lakshmy; Prabhakaran Dorairaj; Mohamad Tarik; Ruby Gupta; Kolli Srinath Reddy
Journal:  Heart Asia       Date:  2012-10-16

2.  Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study.

Authors:  Angela A Rivellese; Lidia Patti; David Kaufman; Jianhui Zhu; Giovanni Annuzzi; Olga Vaccaro; Sven O Ebbesson; Wm James Howard; Gabriele Riccardi; Barbara V Howard
Journal:  Atherosclerosis       Date:  2008-04-18       Impact factor: 5.162

3.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Authors:  F Magkos; B S Mohammed; B Mittendorfer
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

Review 4.  Coronary heart disease in women: why the disproportionate risk?

Authors:  Helen Colhoun
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

5.  LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.

Authors:  Kazuhiko Kotani; Kokoro Tsuzaki; Nobuyuki Taniguchi; Naoki Sakane
Journal:  Int J Prev Med       Date:  2012-03

6.  Sex Differences in the Impact of the Mediterranean Diet on LDL Particle Size Distribution and Oxidation.

Authors:  Alexandra Bédard; Louise Corneau; Benoît Lamarche; Sylvie Dodin; Simone Lemieux
Journal:  Nutrients       Date:  2015-05-15       Impact factor: 5.717

7.  Hematological and biochemical parameters for Chinese rhesus macaque.

Authors:  Wenhai Yu; Xianhui Hao; Fengmei Yang; Jin Ma; Yuan Zhao; Yanyan Li; Junbin Wang; Hongjie Xu; Lixiong Chen; Quan Liu; Suqin Duan; Yaping Yang; Fen Huang; Zhanlong He
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.